OPERATING SEGMENTS (Tables)

9 Months Ended

Sep. 30, 2024

OPERATING SEGMENTS

Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

	December 31, 2023
	2023 Reported					Fixed	2023 Reported
	Valued at 2023				Currency		Valued at 2024
(millions)	Management Rates		Other		Rate Change		Management Rates
Net Sales
Global Industrial		$7,193.1		$407.3		$40.1		$7,640.5
Global Institutional & Specialty		4,994.0		-		20.6		5,014.6
Global Healthcare & Life Sciences		1,576.9		-		30.6		1,607.5
Global Pest Elimination		-		1,061.5		8.7		1,070.2
Other		1,442.3		(1,442.3)		-		-
Corporate		69.1		(26.5)		0.1		42.7
Subtotal at fixed currency rates		15,275.4		-		100.1		15,375.5
Effect of foreign currency translation		44.8		-		(100.1)		(55.3)
Consolidated reported GAAP net sales		$15,320.2		$-		$-		$15,320.2
Operating Income
Global Industrial		$1,080.7		$39.0		$2.3		$1,122.0
Global Institutional & Specialty		823.0		14.9		3.9		841.8
Global Healthcare & Life Sciences		160.0		(6.7)		7.5		160.8
Global Pest Elimination		-		209.0		1.4		210.4
Other		255.0		(255.0)		-		-
Corporate		(331.7)		(1.2)		0.1		(332.8)
Subtotal at fixed currency rates		1,987.0		-		15.2		2,002.2
Effect of foreign currency translation		5.3		-		(15.2)		(9.9)
Consolidated reported GAAP operating income		$1,992.3		$-		$-		$1,992.3

Schedule of financial information for each of the entity's reportable segments

	Third Quarter Ended				Nine Months Ended
	September 30				September 30
(millions)	2024		2023		2024		2023
Net Sales
Global Industrial		$1,993.0		$1,940.8		$5,790.7		$5,655.4
Global Institutional & Specialty		1,403.6		1,314.1		4,046.6		3,719.0
Global Healthcare & Life Sciences		334.1		408.3		1,112.0		1,189.7
Global Pest Elimination		308.7		283.1		872.6		797.4
Corporate		-		10.7		-		32.0
Subtotal at fixed currency rates		4,039.4		3,957.0		11,821.9		11,393.5
Effect of foreign currency translation		(40.9)		1.1		(85.7)		(11.7)
Consolidated reported GAAP net sales		$3,998.5		$3,958.1		$11,736.2		$11,381.8
Operating Income
Global Industrial		$349.1		$299.1		$926.0		$783.8
Global Institutional & Specialty		325.6		254.9		894.3		598.4
Global Healthcare & Life Sciences		35.8		44.7		106.5		113.3
Global Pest Elimination		63.1		59.0		174.1		155.9
Corporate		281.5		(91.6)		138.9		(248.3)
Subtotal at fixed currency rates		1,055.1		566.1		2,239.8		1,403.1
Effect of foreign currency translation		(10.3)		(0.1)		(20.2)		(0.8)
Consolidated reported GAAP operating income		$1,044.8		$566.0		$2,219.6		$1,402.3